Search Within

Jessica W Schulman

Formats
  1. Meeting Abstract (9)
  2. Journal Article (7)
Groups
  1. Center for Hematologic Malignancies (16)
  2. GSK Faculty (15)
  3. Adult Leukemia (14)
  4. Department of Medicine (14)
  5. Hematologic Malignancies, Division of (14)
  6. Sloan Kettering Institute Postdocs (14)

More Groups

People
  1. Christopher Famulare (12)
  2. Minal Patel (12)
  3. Ross Levine (12)
  4. Sean Devlin (9)
  5. Bartlomiej Getta (8)
  6. Martin Tallman (8)

More People

Years
  1. 2023 (1)
  2. 2020 (4)
  3. 2019 (3)
  4. 2018 (6)
  5. 2017 (2)
Publications
  1. Blood (8)
  2. American Journal of Hematology (1)
  3. Cancer Research (1)
  4. Clinical Lymphoma, Myeloma and Leukemia (1)
  5. Haematologica (1)
  6. Leukemia (1)

More Publications

Publishers
  1. American Society of Hematology (8)
  2. Nature Publishing Group (4)
  3. American Association for Cancer Research (1)
  4. Elsevier Inc. (1)
  5. Ferrata Storti Foundation (1)
  6. John Wiley & Sons, Inc. (1)

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
    Journal Article

    Stahl, M.; Derkach, A.; Farnoud, N.; Bewersdorf, J. P.; Robinson, T.; Famulare, C.; Cho, C.; Devlin, S.; Menghrajani, K.; Patel, M. A.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Cancer therapy shapes the fitness landscape of clonal hematopoiesis
    Journal Article

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Kelly, D.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; more...
    Nature Genetics (2020)

    Fulltext@MSK | Save
  • Real-world outcomes of ruxolitinib treatment for polycythemia vera
    Journal Article

    Coltoff, A.; Mesa, R.; Gotlib, J.; Shulman, J.; Rampal, R. K.; Siwoski, O.; Yacoub, A.; Moliterno, A.; Yang, A.; Braunstein, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Prognostic impact of RAS-pathway mutations in patients with myelofibrosis
    Journal Article

    Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Datoguia, T. S.; Puga, R. D.; de Melo Alves Paiva, R.; Arcila, M. E.; Hamerschlak, N.; more...
    Leukemia (2020)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Gao, T.; Devlin, S. M.; Kelly, D.; Coombs, C.; Patel, M.; Moarii, M.; Bernard, E.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia
    Journal Article

    Xiao, W.; Goldberg, A. D.; Famulare, C. A.; Devlin, S. M.; Nguyen, N. T.; Sim, S.; Kabel, C. C.; Patel, M. A.; McGovern, E. M.; Patel, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia
    Journal Article

    Minuesa, G.; Albanese, S. K.; Xie, W.; Kazansky, Y.; Worroll, D.; Chow, A.; Schurer, A.; Park, S. M.; Rotsides, C. Z.; Taggart, J.; more...
    Nature Communications (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Prognostic impact of activating mutations of the NRAS/KRAS genes in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF)
    Meeting Abstract

    Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Puga, R. D.; Paiva, R. D. A.; Hamerschlak, N.; Kantarjian, H. M.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save